Inovio Pharmaceuticals Inc. (INO) News Headlines

▮ More

Date

Headline

2/2/2023 8:31:32 AM INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

2/2/2023 8:00:52 AM INOVIO Reports Positive Phase 1b Results For INO-4201 As Ebola Booster For RVSV-ZEBOV

1/31/2023 8:10:33 AM INOVIO Announces 11% Headcount Reduction

1/31/2023 8:04:47 AM INOVIO Announces Cost-saving Measures Include 11% Headcount Reduction; Annual Savings Expected To Be About $4.3 Mln

11/8/2022 4:37:15 PM Inovio Pharmaceuticals Inc. Q3 Loss decreases, beats estimates

11/8/2022 4:08:08 PM INOVIO Q3 Loss/share $0.15 Vs. Loss $0.29 Year Ago

10/13/2022 8:13:04 AM INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

10/13/2022 8:01:11 AM INOVIO Reports Positive Interim Phase 1/2 Results For INO-3107 For Recurrent Respiratory Papillomatosis

9/19/2022 7:00:38 AM Pre-market Movers: BCAN, REUN, FOXO, ETNB, INO…

9/1/2022 8:01:10 AM INOVIO Reports Inducement Grants Under Inducement Plan

9/1/2022 8:00:00 AM INOVIO Reports Inducement Grants Under Inducement Plan (Press Release)

8/9/2022 4:13:19 PM Inovio Pharmaceuticals Inc. Q2 Loss increases, misses estimates

8/9/2022 4:10:55 PM INOVIO Q2 Loss/share $0.46 Vs. Loss $0.39 Year Ago

7/19/2022 8:14:14 AM INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses

7/19/2022 8:04:35 AM INOVIO Announces Reorganization, Incl 18% Workforce Reduction In Full-time Employees And 86% Reduction In Contractors

7/1/2022 7:01:35 AM Pre-market Movers: INO, CLSK, BORR, KSS, HNRG…

6/27/2022 8:02:26 AM INOVIO Appoints Michael Sumner As Chief Medical Officer

5/27/2022 8:03:55 AM INOVIO Announces Survival Results For INO-5401 + INO-9012 In With Libtayo In Patients With Newly Diagnosed GBM At ASCO

5/19/2022 7:32:13 AM Pre-market Movers: CIG, NOVN, INO, BGXX, CSCO…

5/11/2022 7:29:46 AM Pre-market Movers: U, ELBM, RCUS, EVEX, INO…